Screener
Bioventus BVS Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Bioventus’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:43 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001665988-26-000042
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|---|---|
| Restructuring costs | (415) | — | 39 | — |
| Depreciation and amortization | 1,041 | 1,439 | 2,148 | 3,032 |
| Loss on disposals | — | 1 | — | 82 |
| Operating income | 19,127 | 18,368 | 27,543 | 23,237 |
| Interest expense, net | 4,068 | 7,494 | 8,394 | 15,003 |
| Other (income) expense | (249) | 561 | (676) | 1,338 |
| Other expense | 3,819 | 8,055 | 7,718 | 16,341 |
| Income before income taxes | 15,308 | 10,313 | 19,825 | 6,896 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bioventus's operating income?
- Bioventus (BVS) reported operating income of $19.13M in Q2 2026.
- How has Bioventus's operating income changed year-over-year?
- Bioventus's operating income increased by 4.1% year-over-year, from $18.37M to $19.13M.
- What is the long-term trend for Bioventus's operating income?
- Over 2 years (2022 to 2025), Bioventus's operating income has grown at a -43.2% compound annual growth rate (CAGR), from -$167.23M to $53.98M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Bioventus's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude